Orange peel is rich in the flavonoid hesperidin and soluble fiber. The strongest human evidence shows it modestly lowers cholesterol and triglycerides and eases some blood-vessel inflammation. A blood-pressure benefit appears only in people with metabolic disease, and the blood-sugar claim has not held up consistently. It is cheap and safe, but poorly and unpredictably absorbed. (Full Review)
| Marker | Target | Why |
|---|---|---|
| LDL cholesterol | < 100 mg/dL (often < 70 mg/dL for higher-risk individuals) | Primary outcome; the best-supported benefit |
| Triglycerides | < 80 mg/dL | Responsive to hesperidin; marker of metabolic health |
| Total cholesterol | < 180 mg/dL | Composite lipid marker shown to fall with hesperidin |
| hs-CRP | < 1.0 mg/L | Tracks the modest anti-inflammatory signal |
| Fasting blood glucose | 70–85 mg/dL | Relevant for those with metabolic disease, where some benefit may occur |
| Systolic blood pressure | < 120 mmHg | Benefit seen specifically in people with type 2 diabetes |
Cadence: Baseline, at 12 weeks (when lipid effects emerge), then every 6–12 months for long-term use.